
Join to view full profile
330 Brookline AveShapiro 8Boston, MA 02215
Phone+1 617-667-0519
Fax+1 617-975-5454
Dr. Frank is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Samuel Frank is a neurologist based in Boston, MA, specializing in movement disorders. He completed his medical degree at Boston University School of Medicine in 1998 and his residency in neurology at the University of Rochester Medical Center in 2002. He holds an academic position as an Associate Professor at Beth Israel Deaconess Medical Center since 2015. Dr. Frank has clinical expertise in movement disorders. He has published multiple articles on topics such as Huntington's disease and Parkinson's disease and has been involved in many clinical trials related to these conditions. His achievements include being recognized as a Fellow by both the American Academy of Neurology and the American Neurological Association and receiving several awards throughout his career.
Education & Training
University of Rochester Medical CenterResidency, Neurology, 1999 - 2002
University of Rochester Medical CenterInternship, Internal Medicine, 1998 - 1999
Boston University School of MedicineClass of 1998
University of RochesterB.A., Biology, 1993
Certifications & Licensure
ME State Medical License Current
MA State Medical License 2004 - 2027
NH State Medical License 2024 - 2024
NY State Medical License 1999 - 2004
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Fellow American Academy of Neurology, 2017
- Fellow American Neurological Association, 2014
- Neurology Alumni Award University of Rochester, 2013
Clinical Trials
- Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort
- A Study in Subjects With Late Prodromal & Early Manifest HD to Assess the Safety, Tolerability, pk, and Efficacy of Pepi
- A Study to Evaluate the Efficacy of Prasinezumab (RO7046015/PRX002) in Participants With Early Parkinson's Disease Start of enrollment: 2017 Jun 27
Publications & Presentations
PubMed
- Practical recommendations for the treatment of chorea associated with Huntington's disease: An expert consensus.Erin Furr Stimming, Jee Bang, Amy Brown, Bisena Bulica, Samuel Frank
Journal of Huntington's Disease. 2026-07-14 - Dementia Incidence in Individuals With Parkinson's Disease in the Framingham Heart Study.Joshi Dookhy, Michael Cummings, Eden Price, Yulin Liu, Santiago Gutierrez-Gomez
Annals of Clinical and Translational Neurology. 2026-07-01 - Toward a Speech-Based Model of Premanifest Huntington's Disease Progression Using Deep Neural Networks.Luis A Sierra, Japleen Kaur, Namhee Kwon, Vinod Subramanian, Raymond Brueckner
Digital Biomarkers. 2026-01-19
Journal Articles
- Patient-Reported Outcome Measures in Huntington Disease: Quality of Life in Neurological Disorders (Neuro-Qol) Social Functioning MeasuresCarlozzi NE, Hahn EA, Goodnight SM, Kratz AL, Paulsen JS, Stout JC, Frank S, Miner JA, Cella D, Gershon RC, Schilling SG, Ready RE, Psychol Assess, 1/29/2017
- Deutetrabenazine: A Review in Chorea Associated with Huntington’s DiseaseHeo Y-A and Scott LJ, Drugs, 1/27/2017
- Patient-reported Outcomes in Huntington’s Disease: Quality of Life in Neurological Disorders (Neuro-QoL) and Huntington’s Disease Health-Related Quality of Life (HDQLI...Carlozzi NE, Ready RE, Frank S, Cella D, Hahn EA, Goodnight SM, Schilling SG, Boileau NR, Dayalu P, Mov Disord, 1/27/2017
Books/Book Chapters
Abstracts/Posters
- Evaluating swallowing function in patients with Huntington Disease enrolled in the First-HD Study.Samuel Frank, Sarah Janicki, Daniel Claassen, David Oakes, Victor Sung, Christina Vaughan and Claudia Testa on behalf of the Huntington Study Group First-HD Investigators, International Parkinson Disease and Movement Disorder Congress, 1/22/2016
- Deutetrabenazine Effect on Total Motor Score in Patients with Huntington Disease (First-HD)Samuel Frank, David Stamler, Victor Sung, Daniel Claassen, Sarah Janicki, Clement Loy, Erin Furr-Stimming, David Oakes and Claudia Testa on behalf of the Huntington St..., American Academy of Neurology, Vancouver, British Columbia, Canada, 1/19/2016
- Rating Swallowing Function in Patients with Huntington Disease Enrolled in the First-HD Study.Daniel Claassen, Samuel Frank, David Stamler, Victor Sung, Sarah Janicki, David Oakes, Christina Vaughan and Claudia Testa on behalf of the Huntington Study Group Firs..., American Academy of Neurology, 1/18/2016
Lectures
- Huntington’s DiseaseBeth Israel Deaconess Medical Center - 1/1/2018
- VMAT2 Inhibitors: The FDA Approval Process and Community Impact.MGH - 1/1/2017
- An Interdisciplinary Approach to Caring for Individuals Affected by Huntington’s Disease and their FamiliesMGH - 1/1/2017
Other
- Are We Making Progress in the Management of Huntington Disease?Frank S, Medscape video, CME
1/16/2016 - Updates from Berlin: New Developments in Huntington's Disease.Frank S, Vindico video, CME
1/15/2016 - Parkinson’s Disease and Michael J. Fox Foundation studyFrank S, New England Cable News
1/26/2014
Press Mentions
Sage Therapeutics to Host Sage Science Spotlight: SAGE-718 in DepthMay 13th, 2021
Possible Huntington's Disease Treatment Being Tested in BostonSeptember 11th, 2019
Even Mild Traumatic Brain Injury May Increase Parkinson’s RiskApril 18th, 2018
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: